Cooper Creek Partners Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Cooper Creek Partners Management’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-800,100	Closed	-$3.93M	–	140
2021 Q3	$3.93M	Hold	800,100	–	–	0.53%	55
2021 Q2	$4.22M	Hold	800,100	–	–	1.08%	38
2021 Q1	$3.84M	Buy	+800,100	New	+$4.18M	1.08%	38

Cooper Creek Partners Management's ADMS Position: Q4 2021 in Review

Cooper Creek Partners Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 800,100 shares — an estimated $3.93M sold.

Cooper Creek Partners Management first reported a position in ADMS in Q1 2021 and held it in 3 quarters. The position peaked at $4.22M in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Cooper Creek Partners Management reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Cooper Creek Partners Management sold 800,100 Adamas Pharmaceuticals shares in Q4 2021, an estimated $3.93M.
Cooper Creek Partners Management first reported a position in Adamas Pharmaceuticals in Q1 2021 and held it in 3 quarters.
Cooper Creek Partners Management's Adamas Pharmaceuticals position peaked at $4.22M in Q2 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Cooper Creek Partners Management's 13F filing for Q4 2021, filed 14 Feb 2022.